Oct 20 (Reuters) – Verrica Pharmaceuticals Inc: * VERRICA PHARMACEUTICALS RECEIVES POSITIVE FEEDBACK FROM THE EUROPEAN MEDICINES AGENCY (EMA) SUPPORTING A CLEAR REGULATORY PATH FORWARD TO FILE FOR APPROVAL OF YCANTH® IN THE EUROPEAN UNION * VERRICA PHARMACEUTICALS INC – PLANS REGULATORY SUBMISSION FOR YCANTH BY Q4 2026 Source text: Further company coverage:
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Mumbai (Maharashtra) [India], March 21: In a world where music and entertainment constantly evolve, few…
Scaling Impact: Desai Foundation Celebrates Reaching 12 Million Lives Surat (Gujarat) [India], March 21: The…
New Delhi [India], March 21: India’s entrepreneurial landscape is changing rapidly. More women today are…
PKF managing trustee, Sundeep Bhutoria (inset). PKF and World WWF-India will jointly present the 6th…
Dr. A.K. Dwivedi’s Campaign Reaches Over 2 Million People Indore (Madhya Pradesh) [India], March 19:…
Surat (Gujarat) [India], March 20: Surat emerged as the meeting point of India’s entrepreneurial leadership…